Somai Pharmaceuticals said it received European Union-Good Manufacturing Practice (EU-GMP) certification from the Portuguese health authority Infarmed.
The certification is an essential step to exporting cannabinoids for medical use to foreign markets.
ADVERTISEMENT
The Lisbon, Portugal-based company, which claims to be the largest pharmaceutical cannabis product manufacturer in Europe, said the certification enables the company to execute its plan to own distribution channels in Australia and Germany.
Because Somai received the EU-GMP certification one week ago, the company said it has not yet exported any medical cannabis but plans to change that soon.
“We will be exporting to nine countries for the next few months: Germany, Australia, United Kingdom, Poland, Italy, Switzerland, Netherlands, Denmark, and Brazil,” CEO Michael Sassano told MJBizDaily via email.
“In addition, our (active pharmaceutical ingredients) are already being looked at in all those countries plus Albania, Malta, Luxembourg, Czechia, and US universities and
Read full article on Marijuana Business Daily
